Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

New obesity management medications, including glucagon-like peptide 1 receptor agonists (GLP-1RAs), have shown high ... same chemical drug under different brand names and labels were separately ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like Ozempic.

Called GLP-1 receptor agonists (GLP-1RAs), the drugs were first ... marketed in slightly different formulations under a range of brand names, including Ozempic and Wegovy. No one predicted that ...